Next Article in Journal
HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models
Next Article in Special Issue
Primary, Secondary, and Tertiary Prevention of Congenital Cytomegalovirus Infection
Previous Article in Journal
COVID-19 and Heart Failure with Preserved and Reduced Ejection Fraction Clinical Outcomes among Hospitalized Patients in the United States
Previous Article in Special Issue
Obesity Induces an Impaired Placental Antiviral Immune Response in Pregnant Women Infected with Zika Virus
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Congenital Zika Syndrome and Disabilities of Feeding and Breastfeeding in Early Childhood: A Systematic Review

by
Evangelia Antoniou
1,*,
Paraskevi Eva Andronikidi
2,
Panagiotis Eskitzis
3,
Maria Iliadou
1,
Ermioni Palaska
1,
Maria Tzitiridou-Chatzopoulou
3,
Nikolaos Rigas
1 and
Eirini Orovou
1,3
1
Department of Midwifery, University of West Attica, Agioy Spyridonos 28, 12243 Egaleo, Greece
2
Faculty of Medicine, University of Crete, 71003 Crete, Greece
3
Department of Midwifery, University of Western Macedonia, 50200 Ptolemaida, Greece
*
Author to whom correspondence should be addressed.
Viruses 2023, 15(3), 601; https://doi.org/10.3390/v15030601
Submission received: 20 December 2022 / Revised: 18 February 2023 / Accepted: 19 February 2023 / Published: 22 February 2023
(This article belongs to the Special Issue Emerging Virus Infections in Adverse Pregnancy Outcomes II)

Abstract

:
Background: The Zika virus outbreak has affected pregnant women and their infants. Affected infants develop microcephaly and other congenital malformations referred to as congenital Zika syndrome. The neurological manifestations of congenital Zika syndrome may result in some feeding disorders, including dysphagia, swallowing dysfunction and choking while feeding. The aim of this study was to assess the prevalence of feeding and breastfeeding difficulties in children with congenital Zika syndrome and to estimate the risk of developing feeding disabilities. Methods: We searched PubMed, Google Scholar and Scopus for studies published from 2017 to 2021. From the total of 360 papers, reviews, systematic reviews, meta-analyses and publications in languages other than English were excluded. Therefore, the final sample of our study consisted of 11 articles about the feeding/breastfeeding difficulties of infants and children with congenital Zika syndrome. Results: Infants and children with congenital Zika syndrome were likely to suffer from feeding difficulties at various levels, including breastfeeding. Dysphagia problems ranged from 17.9% to 70%, and nutritional and non-nutritive suckling of infants was also affected. Conclusions: In addition to continuing to investigate the neurodevelopment of affected children, future research should also focus on the severity of factors influencing the degree of dysphagia, as well as the impact of breastfeeding on the child’s overall development.

1. Introduction

In early 2015, some incidents of patients with symptoms of rash, mild fever, arthralgia and conjunctivitis were reported in northeastern Brazil. After the Chikungunya and dengue infections were ruled out, Zika virus (ZIKV) was detected by reverse transcription-polymerase chain reaction from the sera of eight patients [1]. After Brazil, ZIKV spread rapidly to the Americas, and by March 2017, more than 80 countries worldwide were reporting Zika infection [2]. Zika virus is a flavivirus transmitted by the bite of Aedes aegypti and Aedes albopictus mosquitoes in humans [3]. By the end of September 2015, an increasing number of infants with microcephaly were noted in the northeast of Brazil, thus leading researchers to link vertical transmission in pregnancy with severe fetal malformations [4,5]. These congenital malformations are referred to as congenital Zika syndrome (CZS) and may occur after symptomatic or asymptomatic infection in the mother [6], mainly during the first trimester of pregnancy [7]. CZS includes severe microcephaly, in which the skull has partially collapsed; there is decreased brain tissue, including subcortical calcifications; damage to the back of the eye (including focal retinal pigmentary mottling and macular scarring); and hypertonia soon after birth and clubfoot or arthrogryposis [8,9,10,11]. CZS has also been associated with other central nervous system (CNS) abnormalities, such as brain atrophy and asymmetry, absent or abnormally formed brain structures, neuronal migration disorders (effects on neocortical layer formation such as brain calcifications, lissencephaly, ventriculomegaly and cerebellar hypoplasia) and hydrocephalus. Microcephaly is a malformation in which the size of the head is smaller than expected for the age and gender (more than two standard deviations (SDs) below the mean). It is divided into two types: (a) primary microcephaly, which develops before 32 weeks of gestation or birth, and (b) secondary microcephaly, which develops after gestation or birth [12]. Primary microcephaly, the most important focus of Zika virus, is generally caused due to disturbed neurogenesis (mitosis or progenitor cell function or death of neural progenitors). ZIKV infection can lead to both primary and secondary microcephaly (postnatal onset). However, the secondary form of microcephaly usually relates to the postnatal development and maturation of neurons (reduction in dendrites and synaptic connections, or defects in myelination, or even both mechanisms acting in concert) [12,13]. The sooner ZIKV exposure occurs during pregnancy, the sooner the fetus’s head stops developing and the head circumference meets the clinical definition for congenital microcephaly. More specifically, infection during the first or second trimester increases the risk of congenital microcephaly [14,15] owing to increased placental permissiveness at these periods [16] However, there are cases of children exposed to ZIKV in utero who were born normocephalic and developed a progressive neurodevelopmental delay due to retardation of brain development [17,18].
Swallowing is a complex behavior, involving both reflex and volitional activities implicating more than 30 nerves and muscles [19]. There are four stages that describe the movement of the bolus during swallowing: (a) preparatory stage—after taking the food from the mouth, the bolus is placed on the back of the surface of the tongue, and then the oral cavity is sealed by the contact of the soft palate and the tongue in order to prevent the bolus from entering the pharynx before swallowing; (b) oral propulsive stage—there are differences in the consumption of liquid and solid food. After liquid consumption, the posterior buccal cavity is sealed by tongue–palate contact, while solid food is held in the buccal cavity with the tongue and soft palate moving circularly with jaw movement, allowing buccal–pharyngeal communication [20,21]; (c) pharyngeal stage—this stage occurs rapidly and is characterized by the entry of food into the pharynx and esophagus with simultaneous protection of the airways larynx–trachea, during the passage of food; and (d) esophageal stage—at this stage, relaxation is observed during swallowing to allow the bolus to pass into the stomach. The upper part of the esophagus (cervical) consists of striated muscles, and its lower part (thoracic) of smooth muscles. Therefore, bolus transport in the lower esophagus is regulated by the autonomic nervous system [21]. In addition, eating, swallowing and breathing are connected and synergistic in normal people. More specifically, breathing stops slightly during swallowing due to the closure of the airway and the elevation of the soft palate and due to the nervous suppression of breathing by the brainstem [22]. There are a wide variety of diseases that can be responsible for dysphagia, which are distinguished by structural damage to the area, psychiatric disorders, iatrogenic causes or neurological disorders (neurogenic dysphagia) [23]. Neurogenic dysphagia is mainly caused by damage to the basal ganglia of the brain and cerebral cortex, cerebellum, stem and lower cranial nerves [24].
According to the above, the neurological manifestations of CZS in infants may result in some feeding disorders (dysphagia, choking while feeding), which complicate the already existing situation by increasing the risk of morbidity and mortality through malnutrition [25,26]. For this reason, the WHO guidance recommends that infants born to mothers with suspected, probable or confirmed antenatal ZIKV infection, with or without microcephaly, should be evaluated for neurological abnormalities and feeding problems at follow-up monitoring at least at 3, 9 and 24 months of age [27]. It was observed that even CZS infants with neurologic manifestations that were not very severe (without microcephaly) exhibited dysphagia at birth [28]. A study published in 2019 [29] showed that over 50% of mothers of children with CZS reported breastfeeding difficulties, and this explained the high prevalence of early weaning of ZIKV children. More specifically, less than 20% of children were breastfed continuously at 12 months, while 35% of children without microcephaly breastfed continuously at the same point. Therefore, it seems that in children with microcephaly changes in swallowing, oral motor coordination and suckling make breastfeeding difficult.
Breastfeeding has many short-term and long-term benefits for both mother and infant. Exclusive breastfeeding for the first 6 months is associated with a significant reduction in infection and diseases [30], as well as cognitive, language and motor development in infants [31]. Currently, there are no data reports of ZIKV transmitted to neonates through breastfeeding [32], and for this reason, the WHO, in order to prevent ZIKV transmission, published a recommendation for infants born to mothers with suspected, probable or confirmed ZIKV infection that is similar to that for other infants. This recommendation advocates breastfeeding within the first hour of birth, exclusive breastfeeding for 6 months, introduction of complementary foods and continuation of breastfeeding until the age of 2 years [33]. However, this guideline did not take into account the special feeding requirements of infants affected by CZS.
Thus, the need for a systematic review of the literature was noted in order to find relevant articles concerning the feeding (including breastfeeding) of children with the special needs of CZS. The aim of this study was to assess the prevalence of feeding and breastfeeding in children with CZS and to estimate the risk of developing feeding disabilities.
Nevertheless, feeding abilities differ between neonates, infants and children. For example, suckling and swallowing are already observed from the fetal life stage (14–15th week). Coordination of suckling, breathing and swallowing is developed in neonates from birth. In addition, they adjust suckling according to the different types of milk flow (breast or bottle milk). At the age of 2 months, the infants can move the food from the spoon to the back of the mouth, and between 4 and 6 months, when the infant learns to control the tongue, purees or smooth foods are introduced into the infant’s diet. At the period of 6–12 months the front teeth emerge, so they can chew soft pieces, while between 12 and 24 months, they can cope with most food textures and most foods in the family meal [34].

2. Materials and Methods

2.1. Inclusion and Exclusion Criteria

We included prospective studies as well as cohort and cross-sectional studies from 2017 onwards that evaluated the association between CZS and feeding/breastfeeding disabilities. This review followed the guidance of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [35]. We excluded all studies that (a) were review articles (systematic or not) and letters to the editor; (b) enrolled infants who were not infected by ΖIKV; (c) enrolled infants whose neurodevelopment malformations were not related to CZS, (d) did not report data documenting the strength of the association between CZS and feeding and (e) were not written in the English language.

2.2. Exposure/Outcomes

We defined exposure as all infants diagnosed with CZS. Furthermore, all infants had some degree of neurological impairment, with developmental delays at all levels, hypertonia and pyramidal and extrapyramidal signs.
To investigate our outcome, we included all studies that provided information on feeding and breastfeeding in infants and children with CZS.

2.3. Search Strategy

We searched all published English articles on the following databases: Scopus, PubMed/Medline and Google Scholar, and conducted a literature review from 3 August to 26 October 2022. The terms we used were: infants with CZS OR ZIKV infected infants OR ZIKV and congenital malformations AND breastfeeding outcomes OR breastfeeding problems; infants with CZS OR ZIKV infected infants OR ZIKV and congenital malformations AND feeding problems OR feeding disabilities; and infants with CZS OR ZIKV infected infants OR ZIKV and congenital malformations AND nutritional status OR nutritional deficiency.

2.4. Study Selection

Two authors (E.A. and E.O.) evaluated the titles and abstracts independently. Then, the full texts of all shortlisted articles were retrieved and evaluated for eligibility using the predefined inclusion and exclusion criteria. There were no disagreements; therefore, they were not reviewed by another author.

2.5. Methοdological Quality and Risk of Bias

No significant difference appeared in the methodological quality and risk of bias of the articles. The main problems in all studies were that exposure was not assessed more than once over time, and the outcome assessors were not blinded to the exposure status of the participants because the types of studies did not support this design (Table 1). The quality assessment tool we used was developed by NHLBI and Research Triangle Institute International in 2013 in Washington, USA. It consists of a set of customized quality assessment tools designed to help reviewers focus on concepts that are central to the internal validity of a study. The tools were based on quality assessment methods, concepts and other tools developed by researchers at the Agency for Healthcare Research and Quality (AHRQ) Centers for Evidence-Based Practice, the Cochrane Collaboration, the USPSTF, the Scottish Intercollegiate Guidelines Network Lines and the National Center for Reviews and Dissemination of Health Services [36].
Furthermore, selection bias in all articles was low because participants did not differ in their basic characteristics. Performance bias did not exist because no group of children was exposed to factors that affected the results. The way results were collected was reliable across all articles so detection bias was not present. Finally, no data were hidden from any article so the results were not distorted (reposting bias).

3. Results

The initial search of the databases found 360 papers. After removing all duplicate and “other title subject” papers, 117 remained to be evaluated. Subsequently, 106 papers were removed as they were reviews, systematic reviews, meta-analyses, letters to the editor or published in another language than English. Finally, 11 articles were included in the systematic review (Figure 1).
Four studies had a cohort design [4,29,37,43], three cross-sectional [38,40,42] and two longitudinal [39,41] and two studies were case series [18,25] (Table 2). All research articles were conducted in Brazil, where the highest prevalence of ZIKV occurred [44]. All articles provided data from a serological analysis of anti-Zika antibodies in mothers and infants. All children and infants had undergone imaging tests to document neurological disorders. We also extracted information on mothers’ sociodemographics and, where possible, information on pregnancy data regarding ZIKV exposure. The children’s age ranged between 1 and 24 months.
We identified feeding disabilities in all articles. One of them [37] associated ZIKV with dysphagia, while the remaining 10 articles [4,18,25,29,38,39,40,41,42,43] referred to dysphagia with breastfeeding problems. Finally, all the participants had, in addition to eating disorders, severe neurological disabilities associated with the ZIKV syndrome [4,18,25,29,37,38,39,40,41,42,43].

3.1. Feeding Difficulties

Among the remaining articles, the results of the first one [37] showed that feeding difficulties, severe motor disability, hearing and vision abnormalities and seizures tended to coexist. Dysphagia problems ranged from 17.9% to 70% [4,38] in children with CZS. More specifically, 17.9% of 56 infants infected with ZIKV manifested hypersalivation, choking and reflux in the Soares study [4], while none of the control group of infants showed similar symptoms. Furthermore, in Silva’s study [37], 47% of children with CZS presented feeding difficulties since their diet consisted of liquid, pureed or strained foods. The onset of dysphagia began after the third month of life in eight of the nine infants with CZS in another study [25], while swallowing was abnormal in the entire sample. However, seven of nine infants were unable to swallow a sufficient volume of contrast to allow esophageal transit time analysis. Another important finding was a significant relationship between height at 12 months of age in infants with CZS and dysphagia [40], while there were difficulty swallowing (60%), excessive salivation (57.8%), a requirement for highly processed food, enteral nutrition through gastrostomy and lower than normal weight in a significant number of children with CZS in the study by Oliveira [42]. Finally, Ferreira’s study [38] showed that 70% of children with CZS manifested eating difficulties.

3.2. Breasteeding Difficulties

The infant’s ability to suckle is a necessary condition for the initiation of feeding through breastfeeding. However, nutritional and non-nutritive suckling problems in children with CZS result in breastfeeding difficulties. Abnormal swallowing was confirmed in some studies [25,41,43], while during the 6th month of the infants’ life, breastfeeding rates decreased considerably [4,18,25,29,41,42], and only the minority of them were still breastfeeding at 12 months [29,40,41]. In some studies, an above average percentage of infants did not breastfeed [29,38] and, as a result, a high percentage of infants used a bottle [4,41]. In addition, in the case of control studies, it appeared that lower percentages of infants with microcephaly breastfed exclusively compared to the controls [4,42,43] or had good weight gain [39].
However, a worse nutritional status can be counteracted by the beneficial properties of breastfeeding. The weight of infants who were fed with their mother’s milk, either through breastfeeding, expressing breast milk or using donor milk, was much better than the infants who drank formula milk [39,40].

4. Discussion

The results of this study showed that children with CZS were likely to suffer from feeding difficulties at various levels, including breastfeeding. Several studies have shown that children with CZS have feeding difficulties, which are related to the insufficient suckling ability and dysfunction in the orofacial muscles [45,46]. Feeding difficulties are a well-known phenomenon in children with neurological disabilities. Insufficient control and coordination of the muscles reduce the effectiveness of suckling, chewing and swallowing [47]. Dysphagia in children with neurological disorders is characterized by significant variability, which is determined by the degree of neurological damage [48]. Severe CZS is associated with severe cerebral palsy involving the cortical and subcortical regions, basal ganglia and brainstem. These conditions can cause disturbances in any phase of swallowing [25].
Swallowing that follows the breastfeeding reflex is a voluntary process of the infant that requires optimal functioning of the cerebral cortex, which is not fulfilled in children with CZS [49]. For this reason, a high percentage of infants, according to our results, did not initiate breastfeeding after birth, and as a result, they used the bottle. The feeding bottle is compressed during feeding for slow and continuous swallowing, where milk drips into the infant’s oral cavity without requiring any special effort by the infant [41].
According to our results, the majority of infants who breastfed did not continue to do so past 6 months, and few breastfed for the whole first year of their life. However, we could not determine whether the infants with CZS had dysphagia problems or whether the early introduction of formula feeding was a cause of breastfeeding cessation. Additional explanations could be the mother’s lack of cooperation, her mental distress and the lack of breastfeeding promotion programs for mothers of children with CZS [50,51]. In addition, the use of pacifiers is a widespread cultural habit when raising Brazilian children [52]. Moreover, offering the pacifier to children with CZS may be a means of calming and comforting these infants, whose irritability and crying has been linked to their condition [25]. At the same time, however, the use of baby bottles and pacifiers has been associated with early weaning [53].
There is no recommendation to stop breastfeeding in mothers exposed to ZIKV or in infants exposed intrauterine to ZIKV [54,55], but there can be significant difficulties in establishing and maintaining breastfeeding. Nevertheless, our results confirm the beneficial effects of breastfeeding through maintaining a normal body weight. Breast milk has been shown to have a positive impact on weight gain and weight retention compared to formula milk [56]. In addition, there is convincing evidence for the beneficial properties of breast milk given that the infant’s brain is sensitive to nutrition [57].
A key limitation of the study was that it was conducted only in Brazil; in the future, more cohort studies on the effects of CZS on children’s nutrition from all affected countries are needed. In addition, the registration protocol was not peer reviewed in PROSPERO.

5. Conclusions

For the majority of children with CZS, feeding is a difficult process. In addition to continuing to investigate the neurodevelopment of affected children, future research should also focus on the severity of factors influencing the degree of dysphagia, as well as the impact of breastfeeding on the child’s overall development. It is considered imperative to develop education and psychological support programs for families who have children with CZS. In addition, breastfeeding should be supported by any method possible (breastfeeding, expressing breast milk or donor milk).

Author Contributions

Conceptualization, E.A. and E.O.; methodology, P.E.A. and N.R.; validation, E.A., M.I. and E.P.; investigation, E.A.; resources, N.R. and E.O.; data curation, P.E. and M.T.-C.; writing—original draft preparation, E.A.; writing—review and editing, E.O.; visualization, P.E.A.; supervision, E.A.; project administration, E.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zanluca, C.; de Melo, V.C.A.; Mosimann, A.L.P.; dos Santos, G.I.V.; dos Santos, C.N.D.; Luz, K. First Report of Autochthonous Transmission of Zika Virus in Brazil. Mem. Inst. Oswaldo Cruz 2015, 110, 569–572. [Google Scholar] [CrossRef]
  2. Assesssment and Management of Guillain-Barré Syndrome in the Context of Zika Virus Infection: Interim Guidance Update. Available online: https://www.who.int/publications-detail-redirect/WHO-ZIKV-MOC-16.4-Rev.1 (accessed on 14 October 2022).
  3. CDC. Zika Outcomes Investigation (ZODIAC)|CDC. Centers for Disease Control and Prevention. Available online: https://www.cdc.gov/pregnancy/zika/research/zodiac.html (accessed on 13 February 2020).
  4. Soares, F.; Abranches, A.D.; Villela, L.; Lara, S.; Araújo, D.; Nehab, S.; Silva, L.; Amaral, Y.; Junior, S.C.G.; Pone, S.; et al. Zika Virus Infection in Pregnancy and Infant Growth, Body Composition in the First Three Months of Life: A Cohort Study. Sci. Rep. 2019, 9, 19198. [Google Scholar] [CrossRef] [Green Version]
  5. Heukelbach, J.; Alencar, C.H.; Kelvin, A.A.; de Oliveira, W.K.; Pamplona de Góes Cavalcanti, L. Zika Virus Outbreak in Brazil. J. Infect. Dev. Ctries 2016, 10, 116–120. [Google Scholar] [CrossRef]
  6. WHO. Defining the syndrome associated with congenital Zika virus infection. Bull. World Health Organ. 2016, 94, 406. [Google Scholar] [CrossRef]
  7. Zorrilla, C.D.; García García, I.; García Fragoso, L.; De La Vega, A. Zika Virus Infection in Pregnancy: Maternal, Fetal, and Neonatal Considerations. J. Infect. Dis. 2017, 216 (Suppl. 10), S891–S896. [Google Scholar] [CrossRef] [Green Version]
  8. Gullo, G.; Scaglione, M.; Cucinella, G.; Riva, A.; Coldebella, D.; Cavaliere, A.F.; Signore, F.; Buzzaccarini, G.; Spagnol, G.; Laganà, A.S.; et al. Congenital Zika Syndrome: Genetic Avenues for Diagnosis and Therapy, Possible Management and Long-Term Outcomes. J. Clin. Med. 2022, 11, 1351. [Google Scholar] [CrossRef]
  9. CDC. Congenital Zika Syndrome & Other Birth Defects|CDC. Centers for Disease Control and Prevention. Available online: https://www.cdc.gov/pregnancy/zika/testing-follow-up/zika-syndrome-birth-defects.html (accessed on 29 October 2020).
  10. Moore, C.A.; Staples, J.E.; Dobyns, W.B.; Pessoa, A.; Ventura, C.V.; da Fonseca, E.B.; Ribeiro, E.M.; Ventura, L.O.; Neto, N.N.; Arena, J.F.; et al. Characterizing the Pattern of Anomalies in Congenital Zika Syndrome for Pediatric Clinicians. JAMA Pediatr. 2017, 171, 288–295. [Google Scholar] [CrossRef] [Green Version]
  11. Del Campo, M.; Feitosa, I.M.L.; Ribeiro, E.M.; Horovitz, D.D.G.; Pessoa, A.L.S.; França, G.V.A.; García-Alix, A.; Doriqui, M.J.R.; Wanderley, H.Y.C.; Sanseverino, M.V.T.; et al. The Phenotypic Spectrum of Congenital Zika Syndrome. Am. J. Med. Genet. A 2017, 173, 841–857. [Google Scholar] [CrossRef] [Green Version]
  12. Devakumar, D.; Bamford, A.; Ferreira, M.U.; Broad, J.; Rosch, R.E.; Groce, N.; Breuer, J.; Cardoso, M.A.; Copp, A.J.; Alexandre, P.; et al. Infectious Causes of Microcephaly: Epidemiology, Pathogenesis, Diagnosis, and Management. Lancet Infect. Dis. 2018, 18, e1–e13. [Google Scholar] [CrossRef] [Green Version]
  13. Gérardin, P.; Ramos, R.C.; Jungmann, P.; de Oliveira, J.R.M.; Amara, A.; Gressens, P. Zika Epidemic: A Step towards Understanding the Infectious Causes of Microcephaly? Lancet Infect. Dis. 2018, 18, 15–16. [Google Scholar] [CrossRef] [Green Version]
  14. Birth Defects|Zika virus|CDC. Available online: https://www.cdc.gov/zika/healtheffects/birth_defects.html (accessed on 14 February 2020).
  15. Driggers, R.W.; Ho, C.-Y.; Korhonen, E.M.; Kuivanen, S.; Jääskeläinen, A.J.; Smura, T.; Rosenberg, A.; Hill, D.A.; DeBiasi, R.L.; Vezina, G.; et al. Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities. N. Engl. J. Med. 2016, 374, 2142–2151. [Google Scholar] [CrossRef]
  16. Teixeira, F.M.E.; Pietrobon, A.J.; Oliveira, L.d.M.; Oliveira, L.M.d.S.; Sato, M.N. Maternal-Fetal Interplay in Zika Virus Infection and Adverse Perinatal Outcomes. Front. Immunol. 2020, 11, 175. [Google Scholar] [CrossRef]
  17. DeSilva, M.; Munoz, F.M.; Sell, E.; Marshall, H.; Tse Kawai, A.; Kachikis, A.; Heath, P.; Klein, N.P.; Oleske, J.M.; Jehan, F.; et al. Congenital Microcephaly: Case Definition & Guidelines for Data Collection, Analysis, and Presentation of Safety Data after Maternal Immunisation. Vaccine 2017, 35 Pt A, 6472–6482. [Google Scholar] [CrossRef]
  18. Peçanha, P.M.; Gomes Junior, S.C.; Pone, S.M.; Pone, M.V.d.S.; Vasconcelos, Z.; Zin, A.; Vilibor, R.H.H.; Costa, R.P.; Meio, M.D.B.B.; Nielsen-Saines, K.; et al. Neurodevelopment of Children Exposed Intra-Uterus by Zika Virus: A Case Series. PLoS ONE 2020, 15, e0229434. [Google Scholar] [CrossRef] [Green Version]
  19. Jones, B. Normal and Abnormal Swallowing: Imaging in Diagnosis and Therapy; Springer Science & Business Media: Berlin/Heidelberg, Germany, 2003. [Google Scholar]
  20. Palmer, J.B.; Rudin, N.J.; Lara, G.; Crompton, A.W. Coordination of Mastication and Swallowing. Dysphagia 1992, 7, 187–200. [Google Scholar] [CrossRef]
  21. Matsuo, K.; Palmer, J.B. Anatomy and Physiology of Feeding and Swallowing–Normal and Abnormal. Phys. Med. Rehabil. Clin. N. Am. 2008, 19, 691–707. [Google Scholar] [CrossRef] [Green Version]
  22. Nishino, T.; Yonezawa, T.; Honda, Y. Effects of Swallowing on the Pattern of Continuous Respiration in Human Adults. Am. Rev. Respir. Dis. 1985, 132, 1219–1222. [Google Scholar] [CrossRef]
  23. Kuhlemeier, K.V. Epidemiology and Dysphagia. Dysphagia 1994, 9, 209–217. [Google Scholar] [CrossRef]
  24. Bakheit, A.M.O. Management of Neurogenic Dysphagia. Postgrad. Med. J. 2001, 77, 694–699. [Google Scholar] [CrossRef] [Green Version]
  25. Leal, M.C.; van der Linden, V.; Bezerra, T.P.; de Valois, L.; Borges, A.C.G.; Antunes, M.M.C.; Brandt, K.G.; Moura, C.X.; Rodrigues, L.C.; Ximenes, C.R. Characteristics of Dysphagia in Infants with Microcephaly Caused by Congenital Zika Virus Infection, Brazil, 2015. Emerg. Infect. Dis. 2017, 23, 1253–1259. [Google Scholar] [CrossRef]
  26. da Silva, A.A.M.; Ganz, J.S.S.; Sousa, P.d.S.; Doriqui, M.J.R.; Ribeiro, M.R.C.; Branco, M.d.R.F.C.; Queiroz, R.C.d.S.; Pacheco, M.d.J.T.; da Costa, F.R.V.; Silva, F.d.S.; et al. Early Growth and Neurologic Outcomes of Infants with Probable Congenital Zika Virus Syndrome. Emerg. Infect. Dis. 2016, 22, 1953. [Google Scholar] [CrossRef]
  27. World Health Organization. Screening, Assessment and Management of Neonates and Infants with Complications Associated with Zika Virus Exposure in Utero: Rapid Advice Guideline. WHO/ZIKV/MOC/16.3 Rev.1; 2016. Available online: https://apps.who.int/iris/handle/10665/204475 (accessed on 15 October 2022).
  28. van der Linden, V. Description of 13 Infants Born During October 2015–January 2016 with Congenital Zika Virus Infection Without Microcephaly at Birth—Brazil. MMWR Morb. Mortal Wkly. Rep. 2016, 65, 1343–1348. [Google Scholar] [CrossRef]
  29. dos Santos, S.F.M.; Soares, F.V.M.; de Abranches, A.D.; da Costa, A.C.C.; Moreira, M.E.L.; de Matos Fonseca, V. Infants with Microcephaly Due to ZIKA Virus Exposure: Nutritional Status and Food Practices. Nutr. J. 2019, 18, 4. [Google Scholar] [CrossRef] [Green Version]
  30. Duijts, L.; Jaddoe, V.W.V.; Hofman, A.; Moll, H.A. Prolonged and Exclusive Breastfeeding Reduces the Risk of Infectious Diseases in Infancy. Pediatrics 2010, 126, e18–e25. [Google Scholar] [CrossRef] [Green Version]
  31. Leventakou, V.; Roumeliotaki, T.; Koutra, K.; Vassilaki, M.; Mantzouranis, E.; Bitsios, P.; Kogevinas, M.; Chatzi, L. Breastfeeding Duration and Cognitive, Language and Motor Development at 18 Months of Age: Rhea Mother-Child Cohort in Crete, Greece. J. Epidemiol. Community Health 2015, 69, 232–239. [Google Scholar] [CrossRef]
  32. Sampieri, C.L.; Montero, H. Breastfeeding in the Time of Zika: A Systematic Literature Review. PeerJ 2019, 7, e6452. [Google Scholar] [CrossRef] [Green Version]
  33. World Health Organization. Infant Feeding in Areas of Zika Virus Transmission; World Health Organization: Geneva, Switzerland, 2016.
  34. Developmental Stages in Infant and Toddler Feeding. Infant & Toddler Forum. Available online: https://infantandtoddlerforum.org/toddlers-to-preschool/growth-and-development-of-toddlers/developmental-stages/ (accessed on 15 January 2023).
  35. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
  36. Study Quality Assessment Tools|NHLBI, NIH. Available online: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools (accessed on 8 October 2022).
  37. Satterfield-Nash, A.; Kotzky, K.; Allen, J.; Bertolli, J.; Moore, C.A.; Pereira, I.O.; Pessoa, A.; Melo, F.; Santelli, A.C.F.E.S.; Boyle, C.A.; et al. Health and Development at Age 19-24 Months of 19 Children Who Were Born with Microcephaly and Laboratory Evidence of Congenital Zika Virus Infection During the 2015 Zika Virus Outbreak-Brazil, 2017. MMWR Morb. Mortal Wkly. Rep. 2017, 66, 1347–1351. [Google Scholar] [CrossRef] [Green Version]
  38. Ferreira, H.N.C.; Schiariti, V.; Regalado, I.C.R.; Sousa, K.G.; Pereira, S.A.; Fechine, C.P.N.D.S.; Longo, E. Functioning and Disability Profile of Children with Microcephaly Associated with Congenital Zika Virus Infection. Int. J. Environ. Res. Public Health 2018, 15, 1107. [Google Scholar] [CrossRef] [Green Version]
  39. dos Santos, S.F.M.; Soares, F.V.M.; de Abranches, A.D.; da Costa, A.C.C.; Gomes-Júnior, S.C.d.S.; Fonseca, V.d.M.; Moreira, M.E.L. Nutritional Profile of Newborns with Microcephaly and Factors Associated with Worse Outcomes. Clinics 2019, 74, e798. [Google Scholar] [CrossRef] [Green Version]
  40. de Carvalho-Sauer, R.d.C.O.; Costa, M.d.C.N.; Paixão, E.S.; de Jesus Silva, N.; Barreto, F.R.; Teixeira, M.G. Cross-Sectional Study of the Anthropometric Characteristics of Children with Congenital Zika Syndrome up to 12 Months of Life. BMC Pediatrics 2020, 20, 479. [Google Scholar] [CrossRef]
  41. Fábia Cabral Cavalcanti, A.; Aguiar, Y.P.C.; Oliveira Melo, A.S.D.; Leite Cavalcanti, A.; D’Ávila, S. Breastfeeding Behavior in Brazilian Children with Congenital Zika Syndrome. Int. J. Dent. 2020, 2020, e1078250. [Google Scholar] [CrossRef] [Green Version]
  42. de Oliveira, A.M.M.; de Melo, E.G.M.; Mendes, M.L.T.; Oliveira, S.J.G.d.S.; Tavares, C.S.S.; Vaez, A.C.; de Vasconcelos, S.J.A.; Santos, H.P.; Santos, V.S.; Martins-Filho, P.R.S. Oral and Maxillofacial Conditions, Dietary Aspects, and Nutritional Status of Children with Congenital Zika Syndrome. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2020, 130, 71–77. [Google Scholar] [CrossRef]
  43. Medeiros, A.M.C.; Jardim-Botelho, A.; Santos, E.M.d.S.; Lopes, A.d.S.A.; Santos, F.B.; de Sá, T.P.L.; Barreto, Í.D.C.; dos Santos, C.A.; Cuevas, L.E.; Gurgel, R.Q. Feeding Methods and Weight Evolution in Newborns with Congenital Microcephaly Due for Zika Virus. Audiol. Commun. Res. 2021, 26. [Google Scholar] [CrossRef]
  44. Lowe, R.; Barcellos, C.; Brasil, P.; Cruz, O.G.; Honório, N.A.; Kuper, H.; Carvalho, M.S. The Zika Virus Epidemic in Brazil: From Discovery to Future Implications. Int. J. Environ. Res. Public Health 2018, 15, 96. [Google Scholar] [CrossRef] [Green Version]
  45. Cauchemez, S.; Besnard, M.; Bompard, P.; Dub, T.; Guillemette-Artur, P.; Eyrolle-Guignot, D.; Salje, H.; Kerkhove, M.D.V.; Abadie, V.; Garel, C.; et al. Association between Zika Virus and Microcephaly in French Polynesia, 2013–2015: A Retrospective Study. Lancet 2016, 387, 2125–2132. [Google Scholar] [CrossRef] [Green Version]
  46. Prata-Barbosa, A.; Martins, M.M.; Guastavino, A.B.; Cunha, A.J.L.A.d. Effects of Zika Infection on Growth. J. De Pediatr. 2019, 95, 30–41. [Google Scholar] [CrossRef]
  47. Taylor, H.; Pennington, L.; Craig, D.; Morris, C.; McConachie, H.; Cadwgan, J.; Sellers, D.; Andrew, M.; Smith, J.; Garland, D.; et al. Children with Neurodisability and Feeding Difficulties: A UK Survey of Parent-Delivered Interventions. BMJ Paediatr. Open 2021, 5, e001095. [Google Scholar] [CrossRef]
  48. CanChild. Available online: https://www.canchild.ca/en/resources/42-gross-motor-function-classification-system-expanded-revised-gmfcs-e-r (accessed on 16 December 2022).
  49. Modrell, A.K.; Tadi, P. Primitive Reflexes. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2022. [Google Scholar]
  50. Matuszczyk, M.; Mika-Stępkowska, P.; Szmurło, A.; Szary, M.; Perlinski, M.; Kierkuś, J. Dietary Management of Infants and Young Children with Feeding Difficulties and Unsatisfactory Weight Gain Using a Nutritionally Complete Hypercaloric Infant Formula. Practical Considerations from Clinical Cases. Postgrad. Med. 2021, 133, 707–715. [Google Scholar] [CrossRef]
  51. Carroll, C.; Booth, A.; Campbell, F.; Relton, C. What Are the Implications of Zika Virus for Infant Feeding? A Synthesis of Qualitative Evidence Concerning Congenital Zika Syndrome (CZS) and Comparable Conditions. PLoS Negl. Trop. Dis. 2020, 14, e0008731. [Google Scholar] [CrossRef]
  52. Cavalcanti, A.L.; Costa, G.M.C.; Celino, S.D.d.M.; Corrêa, R.R.; Ramos, R.A.; Cavalcanti, A.F.C. Born in Chains: Perceptions of Brazilian Mothers Deprived of Freedom about Breastfeeding. Pesqui. Bras. Odontopediatria Clín. Integr 2018, 18, 4144. [Google Scholar] [CrossRef] [Green Version]
  53. Batista, C.L.C.; Ribeiro, V.S.; Nascimento, M.d.D.S.B.; Rodrigues, V.P. Association between Pacifier Use and Bottle-Feeding and Unfavorable Behaviors during Breastfeeding. J. De Pediatr. 2018, 94, 596–601. [Google Scholar] [CrossRef]
  54. WHO. Statement on the 2nd Meeting of IHR Emergency Committee on Zika Virus and Observed Increase in Neurological Disorders and Neonatal Malformations. Available online: https://www.who.int/news/item/08-03-2016-who-statement-on-the-2nd-meeting-of-ihr-emergency-committee-on-zika-virus-and-observed-increase-in-neurological-disorders-and-neonatal-malformations (accessed on 16 December 2022).
  55. World Health Organization. Division of Diarrhoeal and Acute Respiratory Disease Control; Fund (UNICEF), U.N.C. Breastfeeding Counselling: A Training Course; WHO/CDR/93.3-6; World Health Organization: Geneva, Switzerland, 1993. Available online: https://apps.who.int/iris/handle/10665/63428 (accessed on 16 December 2022).
  56. Davanzo, R.; Cannioto, Z.; Ronfani, L.; Monasta, L.; Demarini, S. Breastfeeding and Neonatal Weight Loss in Healthy Term Infants. J. Hum. Lancet 2013, 29, 45–53. [Google Scholar] [CrossRef]
  57. Belfort, M.B. The Science of Breastfeeding and Brain Development. Breastfeed Med. 2017, 12, 459–461. [Google Scholar] [CrossRef]
Figure 1. Flow diagram of included papers.
Figure 1. Flow diagram of included papers.
Viruses 15 00601 g001
Table 1. Methodological quality and risk of bias of included articles.
Table 1. Methodological quality and risk of bias of included articles.
Studies
CriteriaLeal [25], 2017
Brazil
Satterfield
-Nash [37],
2017
Brazil
Ferreira [38], 2018
Brazil
dos Santos [29],
2019
Brazil
dos Santos [39], 2019
Brazil
Soares
[4],
2019
Brazil
Carvalho-
Sauer
[40],
2020
Brazil
Cavalcanti [41],
2020
Brazil
Peçanha [18], 2020
Brazil
Oliveira [42],
2020
Brazil
Medeiros [43],
2021
Brazil
1. Research question clearly statedViruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001
2. Study population clearly specified and definedViruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001
3. Participation rate of eligible persons at least 50%Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001
4. Same or similar study populations,
prespecified inclusion/exclusion criteria
Viruses 15 00601 i002Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001
5. Sample size justificationViruses 15 00601 i002Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001
6. Exposure of interest measured prior to the outcomeViruses 15 00601 i003Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001
7. Sufficient timeframe between exposure and outcomeViruses 15 00601 i002Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i003Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i003
8.The study examined different levels of exposure as related to the outcomeViruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001
9. Clearly defined exposure measuresViruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001
10. Exposure assessed more than once over timeViruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i003Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002
11. Outcome measures clearly definedViruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i002Viruses 15 00601 i001
12. Outcome assessors blinded to the exposure statusViruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002Viruses 15 00601 i002
13. Loss to follow-up after baseline 20% or lessViruses 15 00601 i002Viruses 15 00601 i001Viruses 15 00601 i002Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i002Viruses 15 00601 i001
14. Confounding variables measured and adjusted statisticallyViruses 15 00601 i002Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001Viruses 15 00601 i001
Notes: Viruses 15 00601 i001: low risk of bias; Viruses 15 00601 i002: some concerns (unclear); Viruses 15 00601 i003: high risk of bias.
Table 2. Research studies included in the review.
Table 2. Research studies included in the review.
Author/Year/
Country
DesignNExposureData CollectionFeeding Outcomes
Leal [25], 2017
Brazil
A descriptive, retrospective case-series study 9 Children with dysphagia and CZS
8–24 months of age
From the medical records of three tertiary care institutions Feeding dysphagia and problems with breastfeeding were manifested after the third month of life in eight of the nine infants.
Abnormal swallowing in all infants.
Satterfield-Nash [37],
2017
Brazil
Cohort study 19 Children with CZS 19–24 months of age ZODIAC
research
47% of children presented feeding difficulties.
Ferreira [38], 2018
Brazil
A descriptive cross-sectional study 34 Children 21 months of age with microcephaly due to CZS From rehabilitation services More than 70% of children with microcephaly had severe difficulty eating,
52% of them were not breastfeed
dos Santos [29], 2019
Brazil
Data from a cohort study “Fernandes Figueira National Institute of Women, Children and Adolescent Health—Oswaldo Cruz Foundation” 65 Infants 12–23 months of age with microcephaly A public
institute
80% of the infants were not exclusively breastfed until the 6th month.
53.6% of the mothers reported difficulties with breastfeeding. At the age of 12–23 months, few infants continued breastfeeding.
dos Santos [39], 2019
Brazil
A longitudinal descriptive study 21 Full-term neonates exposed to ZIKV intrauterine A public neonatal intensive care unit CZS was associated with worse nutritional status. Mean weight of infants consuming only human milk (via breastfeeding and/or expressing breast milk and pasteurized milk from the milk bank) tended to be higher than that of infants consuming only infant formula.
Soares [4], 2019
Brazil
Cohort study 115 56 infants who were exposed intrauterine to ZIKV and
59 who were unexposed, all
1–3 months of age
A part of a large cohort study based in Rio de Janeiro, Brazil 17.9% of infected infants presented dysphagia (hypersalivation, choking and reflux) compared to the non-infected infants.
By the third month of age, 48.3% of exposed infants receiving formula milk compared to 22.2% of unexposed infants.
Carvalho-Sauer [40], 2020
Brazil
Cross-sectional study 46 Children up to 12 months of age with CZS Sourced from 22 municipalities in the State of Bahia by convenience sampling56.8% of children had dysphagia.
There was a positive correlation between breastfeeding time and weight at 3 and 6 months of age, and only a minority of these children were still breastfeeding at 12 months.
Cavalcanti [41], 2020
Brazil
Observational, longitudinal study 98 Children 2–17 months of age with CZS Interviews with mothers of children with CZS from two rehabilitation centers 89.9% of children were breastfed at birth; by the age of 6 months, 36.6% continued breastfeeding, 48% had swallowing difficulty and 27.8% had suckling difficulties; use of bottle was reported for 89.9%.
Peçanha [18], 2020
Brazil
An exploratory case series 84Asymptomatic children exposed to ZIKV intrauterine (range 6–18 months)Outpatient clinic at Instituto Fernandes Figueira (IFF)-Fundação Oswaldo Cruz (Fiocruz)Exclusive breastfeeding was maintained in 58.3% of children up to 6 months.
Oliveira [42], 2020
Brazil
Cross-sectional study 4545 children with CZS and 50 healthy controls, all 6 months of ageThree rehabilitation centersDifficulty swallowing (60%), excessive salivation (57.8%) and non-exclusive breastfeeding until 6 months (84.4%).
Ultraprocessed food intake, lower weight and enteral nutrition through gastrostomy or jejunostomy were noted in children with CZS.
Medeiros [43], 2021
Brazil
Retrospective cohort with nested case-control study86Two groups of neonates, with microcephaly (n = 43) and without microcephaly (n = 43)
(from birth to the 37th day of life)
Data were collected from a
maternity hospital in northeastern Brazil
During hospitalization, 34.9% of neonates with microcephaly breastfed exclusively, in contrast to the control group, which breastfed at a rate of 47.4%. A nasogastric feeding tube was used in 23.3% of the microcephaly group, while in the control group, it was used in 7.9%.
58% of the neonates in the control and 70% of the neonates in the control group (without microcephaly) were taken to the maternal breast as soon as they were born.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Antoniou, E.; Andronikidi, P.E.; Eskitzis, P.; Iliadou, M.; Palaska, E.; Tzitiridou-Chatzopoulou, M.; Rigas, N.; Orovou, E. Congenital Zika Syndrome and Disabilities of Feeding and Breastfeeding in Early Childhood: A Systematic Review. Viruses 2023, 15, 601. https://doi.org/10.3390/v15030601

AMA Style

Antoniou E, Andronikidi PE, Eskitzis P, Iliadou M, Palaska E, Tzitiridou-Chatzopoulou M, Rigas N, Orovou E. Congenital Zika Syndrome and Disabilities of Feeding and Breastfeeding in Early Childhood: A Systematic Review. Viruses. 2023; 15(3):601. https://doi.org/10.3390/v15030601

Chicago/Turabian Style

Antoniou, Evangelia, Paraskevi Eva Andronikidi, Panagiotis Eskitzis, Maria Iliadou, Ermioni Palaska, Maria Tzitiridou-Chatzopoulou, Nikolaos Rigas, and Eirini Orovou. 2023. "Congenital Zika Syndrome and Disabilities of Feeding and Breastfeeding in Early Childhood: A Systematic Review" Viruses 15, no. 3: 601. https://doi.org/10.3390/v15030601

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop